Simon Drysdale
BSc (Hons), MBBS, PgDip PID (Oxford), PhD, FRCPCH, FHEA
Senior Vaccine Clinical Trials Paediatrician
- Associate Professor and Consultant in Paediatric Infectious Diseases and Immunology
Vaccines and preventing infections throughout life
Biography
Simon is an associate professor and consultant in paediatric infectious diseases and immunology at the University of Oxford and Children’s Hospital, Oxford. He acts as chief and principal investigator on multiple clinical trials investigating novel diagnostics, treatments, vaccines and monoclonal antibodies for a variety of infectious conditions. Simon is a member of several large European collaborative research studies. His main research interests are maternal and infant vaccinology, management, prevention and host susceptibility to respiratory syncytial virus (RSV) and other respiratory viral infections, and perinatal infections. He is the Royal College of Paediatrics and Child Health (RCPCH) paediatric immunology and infectious diseases college specialty advisory committee (CSAC) co-chair. He also sits on multiple local, national, and international committees related to paediatrics including the UK Department of Health and Social Care’s (DHSC) Joint Committee on Vaccination and Immunisation (JCVI) RSV subcommittee, the Medicines and Healthcare products Regulatory Agency’s (MHRA) Paediatric Medicine Expert Advisory Group (PMEAG), and he is a board member of the European Society of Paediatric Infectious Diseases (ESPID).
Recent publications
-
180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial.
Journal article
Munro APS. et al, (2025), Lancet Child Adolesc Health, 9, 404 - 412
-
Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis.
Journal article
Trusinska D. et al, (2025), EClinicalMedicine, 84
-
Prevention of respiratory syncytial virus disease by immunisation.
Journal article
Benzaken TR. et al, (2025), Arch Dis Child Educ Pract Ed, 110, 117 - 120
-
Recent advances in the prevention and treatment of respiratory syncytial virus disease.
Journal article
Sanchez-Martinez A. et al, (2025), J Gen Virol, 106
-
Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus.
Journal article
Villaverde S. et al, (2025), Pediatr Infect Dis J, 44, 239 - 245

